Suchergebnisse - "De Miguel, Eugenio"

PubPharm (7)

1

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis

enthalten in: Arthritis research & therapy | 2019

von Gratacós, J. | Pontes, C. | Juanola, X. | +40

CommentIn: Nat Rev Rheumatol. 2019 Jun;15(6):322-324. - PMID 30903025

2

Minimal Disease Activity as a Treatment Target in Psoriatic Arthritis : A Review of the Literature

enthalten in: The Journal of rheumatology | 2018

von Gossec, L. | McGonagle, D. | Korotaeva, T. | +4

3

A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis

enthalten in: Rheumatology international | 2017

von de Miguel, E. | Pecondón-Español, A. | Castaño-Sánchez, M. | +7

4

Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis : a systematic literature review

enthalten in: Rheumatology (Oxford, England) | 2016

von Navarro-Compán, V. | Plasencia-Rodríguez, C. | de Miguel, E. | +4

5

Evaluation of dose reduction versus standard dosing for maintenance of remission in patients with spondyloarthritis and clinical remission with anti-TNF (REDES-TNF) : study protocol for a randomized controlled trial

enthalten in: Trials | 2015

von Pontes, C. | Gratacós, J. | Torres, F. | +7

6

Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis : a marker of disease activity in HLA-B27⁺ patients

enthalten in: Rheumatology (Oxford, England) | 2013

von Bautista-Caro, M. | Arroyo-Villa, I. | Castillo-Gallego, C. | +5

7

Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthritis patients

enthalten in: Regulatory peptides | 2003

von Hernanz, A. | Medina, S. | de Miguel, E. | +1

1
[1]